STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

FOXO expands authorized Class A stock to 2.5B shares, effective Oct 22

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

FOXO Technologies Inc. amended its Certificate of Incorporation to increase authorized shares of Class A common stock from 500,000,000 to 2,500,000,000. The amendment, previously authorized and approved by stockholders, became effective on October 22, 2025 with the Delaware Secretary of State.

This change expands the number of shares the company may issue in the future; it does not by itself issue any shares or raise capital. A copy of the amendment is filed as Exhibit 3.1.

Positive

  • None.

Negative

  • None.

Insights

Authorized shares increased; administrative change, neutral impact.

FOXO Technologies increased authorized common shares from 500,000,000 to 2,500,000,000, effective October 22, 2025, via a Delaware Certificate of Amendment that had prior stockholder approval. This is a charter-level capacity change.

The action permits, but does not execute, future equity issuance. Actual effects depend on any subsequent transactions, which are not described in the excerpt. The filing lists the amendment as Exhibit 3.1.

false --12-31 0001812360 0001812360 2025-10-22 2025-10-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date Earliest Event Reported): October 22, 2025

 

FOXO TECHNOLOGIES INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-39783   85-1050265

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

477 South Rosemary Avenue

Suite 224

West Palm Beach, FL

  33401
(Address of Principal Executive Offices)   (Zip Code)

 

(612) 800-0059

(Registrant’s telephone number, including area code)

 

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class A Common Stock, par value $0.0001   N/A   None

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

Pursuant to the authorization and approval previously provided by the stockholders of FOXO Technologies Inc., a Delaware corporation (the “Company”), the Company filed a Certificate of Amendment to its Certificate of Incorporation, as amended, with the Secretary of State of Delaware to increase its authorized shares of Common Stock, $0.0001 par value per share, from 500,000,000 shares to 2,500,000,000 shares, which filing became effective on October 22, 2025 (the “Amendment”). A copy of the Amendment is attached as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated into this Item 5.03 by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit

Number

  Description of Exhibit
3.1   Certificate of Amendment to Certificate of Incorporation filed with the Delaware Secretary of State effective October 22, 2025
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  FOXO Technologies Inc.
     
Date: October 23, 2025 By: /s/ Seamus Lagan
  Name: Seamus Lagan
  Title: Chief Executive Officer

 

3

 

 

FAQ

What did FOXO (FOXO) change in this filing?

The company increased authorized Class A common stock from 500,000,000 to 2,500,000,000 shares through a Certificate of Amendment.

When did the authorized share increase become effective for FOXO?

The amendment became effective on October 22, 2025 with the Delaware Secretary of State.

Was the FOXO authorized share increase approved by stockholders?

Yes. The amendment was made pursuant to authorization and approval previously provided by the stockholders.

Does this FOXO change issue new shares or raise capital now?

No. Increasing authorized shares changes capacity only; it does not itself issue shares or raise proceeds.

Where can I find the FOXO amendment document?

It is filed as Exhibit 3.1: Certificate of Amendment to the Certificate of Incorporation.

Is FOXO’s Class A common stock listed on an exchange?

The filing lists the trading symbol as N/A and the exchange as None for Class A common stock.
FOXO TECHNOLOGIES

OTC:FOXO

FOXO Rankings

FOXO Latest News

FOXO Latest SEC Filings

FOXO Stock Data

1.04M
76.60M
0.21%
0.25%
4.32%
Health Information Services
Services-commercial Physical & Biological Research
Link
United States
WEST PALM BEACH